Safety and efficacy of QW7437, a new fluorocarbon-based echocardiographic contrast agent

Journal of the American Society of Echocardiography

Volumn 10, Issue 8, 1997, Pages 798-804

  Main, Michael L ^b   Escobar, Jose F ^b   Hall, Shelley A ^b   Grayburn, Paul A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FLUOROCARBON; MICROSPHERE; QW7437;

ANIMAL; ARTICLE; CORONARY ARTERY BLOOD FLOW; DOG; DRUG EFFECT; ECHOCARDIOGRAPHY; EVALUATION; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; IMAGE ENHANCEMENT; METHODOLOGY;

ANIMALS; CONTRAST MEDIA; CORONARY CIRCULATION; DOGS; ECHOCARDIOGRAPHY; EVALUATION STUDIES; FLUOROCARBONS; HEMODYNAMIC PROCESSES; IMAGE ENHANCEMENT; MICROSPHERES; VENTRICULAR FUNCTION, LEFT;

EID: 0031254169     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0894-7317(97)70038-5     Document Type: Article

References (22)

1. Villanueva FS, Glasheen WP, Sklenar J, Jayaweera AR, Kaul S. Successful and reproducible myocardial opacification during two-dimensional echocardiography from right heart injection of contrast. Circulation 1992;85:1557-64.
2. Grayburn PA, Erickson JM, Escobar JF, Womack L, Velasco CE. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardiol 1995;26:1340-7.
3. Meza M, Greener Y, Hunt R, et al. Myocardial contrast echocardiography: reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent. Am Heart J 1996;132:871-81.
4. Dittrich HC, Bales GL, Kuvelas T, Hunt RM, McFerran BA, Greener Y. Myocardial contrast echocardiography in experimental coronary occlusion with a new intravenously administered contrast agent. J Am Soc Echocardiogr 1995;8:465-74.
5. Skyba, DM, Camarano G, Goodman BS, Price RJ, Skalak TC, Kaul S. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol 1996;28:1292-300.
6. Beppu S, Matsuda H, Shishido T, Matsumura M, Miyatake K. Prolonged myocardial contrast echocardiography via peripheral venous administration of QW3600 injection (EchoGen): its efficacy and side effects. J Am Soc Echo 1997;10:11-24.
7. Grauer SE, Pantely GA, Xu J, et al. Myocardial imaging with a new transpulmonary lipid-fluorocarbon echo contrast agent: experimental studies in pigs. Am Heart J 1996;132:938-45.
8. Porter TR, Xie F. Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight, less soluble gases. J Am Goll Cardiol 1995;25:509-15.
9. Porter TR, Xie F, Kilzer K. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces visually evident myocardial ultrasound contrast which correlates with coronary blood flow. J Am Soc Echocardiogr 1995;8:710-8.
10. Porter TR, Xie F, Kricsfeld D, Armbruster RW. Improved myocardial contrast with second harmonic transient response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albumin. J Am Coll Cardiol 1996; 27:1497-501.
11. Porter TR, Xie F. Transient myocardial contrast following initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: demonstration and potential mechanisms. Circulation 1995;92:2391-5.
12. Grayburn PA, Hack T, Weiss JL, et al. A phase 3 trial comparing dodecafluoropentane (EchoGen) and sonicated albumin (Albunex) in patients with suboptimal echoes [abstract]. Circulation 1996;94:I-575.
13. Schrope BA, Newhouse VL. Second harmonic ultrasonic blood perfusion measurement. Ultrasound Med Biol 1993; 19:567-79.
14. Miller DL. Ultrasonic detection of resonant cavitation bubbles in a flow tube by their second harmonic emissions. Ultrasonics 1981;19:217-24.
15. de Jong N, Ten Cate FJ, Lancee CT, Roelandt TR, Bom N. Principles and recent developments in ultrasound contrast agents. Ultrasonics 1991;29:324-30.
16. de Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres. Part one: simulations. Ultrasonics 1994;32:447-53.
17. de long N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres. Part two: measurements. Ultrasonics 1994;32:455-9.
18. Kowallik P, Schulz R, Guth BD, et al. Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation 1991;83:974-82.
19. Keller MW, Segal SS, Kaul S, Duling B. The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography. Circ Res 1989;65:458-67.
20. Jayaweera AR, Edwards N Glasheen WP, Villanueva FS, Abbott RD, Kaul S. In-vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echo-cardiography: comparison with radiolabeled red blood cells. Circ Res 1994;74:1157-65.
21. Lindner JR, Kaul S. Insights into the assessment of myocardial perfusion offered by the different currently used cardiac imaging modalities. J Nucl Cardiol 1995;2:446-60.
22. Porter TR, Xie F, Kricsfeld A, Deligonal U, Kilzer K. Reduction in left ventricular cavitary attenuation and improvement in posterior myocardial contrast with higher molecular weight intravenous perfluorocarbon-exposed sonicated dextrose albumin microbubbles. J Am Soc Echocardiogr 1996;9:437-41.